From host-cell state to therapeutic opportunity

Projects in the lab cover HIV persistence, hypoxia- and purinergic control of infection and inflammatory host signaling, as well as virus-induced cellular remodeling. To dissect these processes, we combine infection assays, flow cytometry, imaging, CRISPR-based perturbation, drug testing, and systems-level transcriptomic approaches — linking cellular mechanisms to therapeutic vulnerabilities.